Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report

Leukemia Research

Volumn 34, Issue 9, 2010, Pages 1175-1179

  Yun, Jina ^a   Kim, Seok Jin ^a   Won, Jong Ho ^b   Choi, Chul Won ^c   Eom, Hyeon Seok ^d   Kim, Jin Seok ^e   Kim, Min Kyoung ^f   Kwak, Jae Yong ^g   Kim, Won Seog ^a   Suh, Cheolwon ^h  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d National Cancer Center   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f Yeungnam University College of Medicine   (South Korea)

^g Chonbuk National University Medical School and Hospital   (South Korea)

^h University of Ulsan College of Medicine   (South Korea)

Author keywords

B cell; Chemotherapy; Lymphoma; Ovary; Prognosis; Rituximab; T cell

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL DISTENSION; ABDOMINAL MASS; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MARGINAL ZONE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; OVARIAN LYMPHOMA; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT RESPONSE;

EID: 77955281346     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.02.010     Document Type: Article

References (11)

1. Dimopoulos M.A., Daliani D., Pugh W., Gershenson D., Cabanillas F., Sarris A.H. Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy. Gynecol Oncol 1997, 64:446-450.
2. Osborne B.M., Robboy S.J. Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases. Cancer 1983, 52:1933-1943.
3. Lagoo A.S., Robboy S.J. Lymphoma of the female genital tract: current status. Int J Gynecol Pathol 2006, 25:1-21.
4. Kosari F., Daneshbod Y., Parwaresch R., Krams M., Wacker H.H. Lymphomas of the female genital tract: a study of 186 cases and review of the literature. Am J Surg Pathol 2005, 29:1512-1520.
5. Nelson G.A., Dockerty M.B., Pratt J.H., Remine W.H. Malignant lymphoma involving the ovaries. Am J Obstet Gynecol 1958, 76:861-871.
6. Woodruff J.D., Noli C., Novak E.R. Lymphoma of the ovary. A study of 35 cases from the Ovarian Tumor Registry of the American Gynecological Society. Am J Obstet Gynecol 1963, 85:912-918.
7. Monterroso V., Jaffe E.S., Merino M.J., Medeiros L.J. Malignant lymphomas involving the ovary. A clinicopathologic analysis of 39 cases. Am J Surg Pathol 1993, 17:154-170.
8. Carbone P.P., Kaplan H.S., Musshoff K., Smithers D.W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971, 31:1860-1861.
9. Pfreundschuh M., Trumper L., Osterborg A., Pettengell R., Trneny M., Imrie K., et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006, 7:379-391.
10. Choi M.K., Jun H.J., Lee S.Y., Kim K.H., Lim do H., Kim K., et al. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea. Ann Hematol 2009, 88:1099-1106.
11. Chang M.H., Kim S.J., Kim K., Oh S.Y., Lee D.H., Huh J., et al. Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea. Leuk Lymphoma 2009, 50:1119-1125.